Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients
NCT ID: NCT05056831
Last Updated: 2024-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2021-06-21
2024-10-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity and Healthy Eating Among Young Adult Cancer Survivors
NCT05887401
Barriers Affecting Physical Activity
NCT03573375
Effectiveness of a Cancer Exercise Program
NCT06039488
Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies
NCT03569605
Sustaining Physical Activity After Cancer Exercise Sessions
NCT06359210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To adapt a multicomponent intervention (HH+AIM) that assesses the perspective of health care provider and cancer survivors about:
Ia. Needs related to psychosocial distress and health behaviors in rural patients with cancer.
Ib. Needs related to implementing interventions within the treatment setting. Ic. Barriers to intervention delivery/participate. Id. Preferred means/methods for referring participants and receiving information related to the intervention.
SECONDARY OBJECTIVES:
I. To assess time spent sitting in prolonged bouts of 20 consecutive minutes or more (minutes/day).
II. To assess daily number of steps (collected using the activPAL over 7 days at week 8, data will be averaging over 7 days to get minutes per day).
III. To assess psychosocial distress measured using the National Comprehensive Cancer Network (NCCN) Distress Thermometer scores.
IV. To assess health-related quality of life measured using the SF-36 short form.
OUTLINE:
PART I: Patients and providers complete a questionnaire and attend an interview over 1 hour.
PART II: Patients are randomized to 1 of 2 groups.
GROUP I: Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.
GROUP II: Patients receive usual care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (physical activity intervention)
Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.
Behavioral Intervention
Attend face-to-face mind-body sessions
Informational Intervention
Receive targeted text messages
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Group II (usual care)
Patients receive usual care.
Best Practice
Receive usual care
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral Intervention
Attend face-to-face mind-body sessions
Best Practice
Receive usual care
Informational Intervention
Receive targeted text messages
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PROVIDERS: Place of engagement falls within a rural county in Texas
* PROVIDERS: Able to read, speak, and write in English
* PROVIDERS: At least 18 years old
* PROVIDERS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVIEW SURVIVORS: Men and women \>= 18 years of age
* INTERVIEW SURVIVORS: History of cancer
* INTERVIEW SURVIVORS: Currently receiving treatment or have recently completed treatment but are still attending appointments at UTHealth North Campus Tyler (=\< 1 year)
* INTERVIEW SURVIVORS: Able to read, speak, and write in English
* INTERVIEW SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVENTION SURVIVORS: Men and women \>= 18 years of age
* INTERVENTION SURVIVORS: Received a solid tumor cancer diagnosis stage I-III
* INTERVENTION SURVIVORS: Receiving radiation therapy or planning to receive radiation therapy for a solid tumor diagnosis for at least 4 weeks
* INTERVENTION SURVIVORS: Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner)
* INTERVENTION SURVIVORS: Physician clearance to participate in the study
* INTERVENTION SURVIVORS: Physically inactive (=\< 60 minutes of moderate or greater physical activity \[PA\] per week during the past 6 months)
* INTERVENTION SURVIVORS: Live within MD Anderson's rural catchment area
* INTERVENTION SURVIVORS: Have a home address where information can be mailed and a working telephone
* INTERVENTION SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
* INTERVENTION SURVIVORS: Able to read, speak, and write in English
* INTERVENTION SURVIVORS: Able to receive text messages on their smartphone (via cellular data or wireless internet)
Exclusion Criteria
* PROVIDERS: Place of work or engagement falls within an urban/metropolitan county in Texas
* PROVIDERS: Does not read, speak, or write in English
* PROVIDERS: Below the age of 18 years
* INTERVIEW SURVIVORS: No history of cancer
* INTERVIEW SURVIVORS: Does not read, speak, or write in English
* INTERVIEW SURVIVORS: Below the age of 18
* INTERVENTION SURVIVORS: No history of cancer
* INTERVENTION SURVIVORS: Have absolute contraindications to unassisted physical activity (e.g., acute myocardial infarction, severe orthopedic or musculoskeletal limitations)
* INTERVENTION SURVIVORS: Currently participating in another intervention to increase physical activity or reduce sedentary behavior
* INTERVENTION SURVIVORS: Self-report meeting physical activity recommendations (\>= 60 minutes of moderate or greater PA per week during the past 6 months)
* INTERVENTION SURVIVORS: Physical limitations that might be aggravated by participation in moderate-intensity physical activity as measured using the Physical Activity Readiness Questionnaire (PAR-Q), and any physical limitation that prevents engaging in moderate intensity exercise
* INTERVENTION SURVIVORS: Primary address falls within an urban/metropolitan county in Texas
* INTERVENTION SURVIVORS: Plan to move from the area or discontinue their treatment at UTHealth North Campus Tyler during the 14-week study period
* INTERVETION SURVIVORS: Does not read, speak, or write in English
* INTERVENTION SURVIVORS: Below the age of 18
* INTERVENTION SURVIVORS: Pregnant or planning to become pregnant during the 14 week study period
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Kawut, Steven, MD
INDIV
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scherezade Mama, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-09572
Identifier Type: REGISTRY
Identifier Source: secondary_id
2020-1278
Identifier Type: OTHER
Identifier Source: secondary_id
2020-1278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.